Treating Sleep Apnea May Reduce Dementia Risk

People with obstructive sleep apnea who treat their apnea with the commonly-prescribed positive airway pressure therapy were less likely to be diagnosed with dementia.

7:10 PM

Author | Haley Otman

drawing of a brain in blue ink on lined paper with "lab note" branding on bottom right
Michigan Medicine

A new study finds older adults who received positive airway pressure therapy prescribed for obstructive sleep apnea may be less likely to develop Alzheimer's disease and other kinds of dementia. 

Researchers from Michigan Medicine's Sleep Disorders Centers analyzed Medicare claims of more than 50,000 Medicare beneficiaries ages 65 and older who had been diagnosed with OSA. In this nationally representative study, they examined if those people who used positive airway pressure therapy were less likely to receive a new diagnosis of dementia or mild cognitive impairment over the next 3 years, compared to people who did not use positive airway pressure.

"We found a significant association between positive airway pressure use and lower risk of Alzheimer's and other types of dementia over three years, suggesting that positive airway pressure may be protective against dementia risk in people with OSA," says lead author Galit Levi Dunietz, Ph.D., M.P.H., an assistant professor of neurology and a sleep epidemiologist.

The findings stress the impact of sleep on cognitive function. "If a causal pathway exists between OSA treatment and dementia risk, as our findings suggest, diagnosis and effective treatment of OSA could play a key role in the cognitive health of older adults," says study principal investigator Tiffany J. Braley, M.D., M.S., an associate professor of neurology. 

Obstructive sleep apnea is a condition in which the upper airway collapses repeatedly throughout the night, preventing normal breathing during sleep. OSA is associated with a variety of other neurological and cardiovascular conditions, and many older adults are at high risk for OSA.

And dementia is also prevalent, with approximately 5.8 million Americans currently living with it, Braley says.

Dunietz, Braley and co-authors Ronald D. Chervin, M.D., M.S., and James Burke, M.D., M.S., are all part of the University of Michigan's Institute for Healthcare Policy & Innovation. Alan Conceicao also served as a co-author on the publication. This study was supported by the American Sleep Medicine Foundation/American Academy of Sleep Medicine (award #115-SR-15).

Paper cited: "Obstructive Sleep Apnea Treatment and Dementia Risk in Older Adults," Sleep. DOI: 10.1093/sleep/zsab076


More Articles About:

Lab Notes Neurological (Brain) Conditions Sleep Apnea Sleep Disorders Treatment Geriatrics Sleep Disorders
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Cole, wearing sunglasses and a purple Calming the Storm t-shirt with a rainbow, is seated on a blanket outdoors and holding a Mott teddy bear.
Philanthropy News

A pediatric epilepsy fundraiser that changes lives

Your support of Calming the Storm advances pediatric epilepsy research and patient care programs. There are many ways you can contribute to make a difference for so many children and families.
Catheterized hospital patient's leg
Health Lab

Many hospitals still don’t do enough to prevent UTIs from catheters

Urinary catheters used by hospitals can lead to UTIs, bladder infections and bloodstream infections, yet hospital infection prevention efforts lag even after 20 years of effort.
Doctor performing a test
News Release

Michigan Alzheimer's Disease Research Center receives $22M to advance efforts statewide

NIH renews $22M for Michigan Alzheimer's Disease Research Center, supporting a first-of-its-kind statewide partnership and dementia research.
cells close up blue and green background microscope
Health Lab

Engineered nanoparticles sensitize gliomas to radiotherapy

University of Michigan researchers discovered a new pathway that sensitizes mIDH1 gliomas to radiation in human and mouse mIDH1 glioma cells and mouse models, paving the way for phase 1 clinical trials in humans
blue background bucket poured on helment
Health Lab

5 things to know about ALS

A Michigan Medicine expert answers questions about this degenerative neurological disease and the work in process to defeat it.
woman with older woman at table helping on tablet
Health Lab

First person-centered measure of dementia caregiving styles improves partner, patient outcomes

First person-centered measure of dementia caregiving styles improves partner and patient outcomes.